Heart Failure & Cardiomyopathy

Contact Information

Boswell Building
Room A260 (2nd floor)
300 Pasteur Drive
Stanford, CA 94305

Phone: (650) 723-5468
Fax: (650) 498-4531

Monday - Friday
8:30am - 5:00pm

Driving Directions

Stanford has the accumulated wisdom of many years of research and continues to develop the latest advancements in the diagnosis and treatment of congestive heart failure and cardiomyopathy. For example, Stanford researchers were instrumental in the development of left ventricular assist device (LVAD) therapy, leading to the first successful bridge to transplant implant in 1984 at Stanford by Dr. Philip Oyer.

For patients, this translates into a multidisciplinary program that includes cardiologists specializing in heart failure management, cardiovascular surgeons, electrophysiologists, radiologists, and molecular biologists. Stanford's cardiothoracic surgeons are pioneers in restorative techniques for the heart, coupling longstanding experience with innovative approaches.

The heart failure group has a long tradition of internationally recognized research, beginning with the pivotal trials of beta blocker therapy conducted by Michael B. Fowler, MD, FRCP, the director of the cardiomyopathy center. Current research interests include the role of insulin resistance in the development and treatment of cardiomyopathy, new approaches to the diagnosis and treatment of cardiomyopathy using genetic testing, novel therapies for amyloid cardiomyopathy, cardio-oncology, and heart failure improvement measures.

Our areas of treatment expertise include:

Additional Resources

Stanford Medicine Resources:

Footer Links: